极至中度早产与53岁时肺功能缺陷及慢阻肺的关联:前瞻性队列研究分析
基于塔斯马尼亚纵向健康研究(TAHS)1445名参与者的前瞻性队列分析,在53岁时测量肺功能,按孕周分为极早产(28周至<32周)、中度早产(32周至<34周)、晚期早产(34周至<37周)和足月(≥37周)。与足月产相比,极至中度早产与53岁时慢阻肺风险增加(OR 2.9,95%CI 1.1-7.7)及支气管舒张后FEV1/FVC比值降低(β=-2.9%,95%CI -4.9至-0.81)、FEV1降低(-190 mL,95%CI -339至-40)、DLCO降低(-0.55 mmol/min/kPa,95%CI -0.97至-0.13)、FEF25-75%降低(-339 mL/s,95%CI -664至-14)相关。极至中度早产与FEV1/FVC比值的关联仅在吸烟者中显著(交互作用P=0.0082)。晚期早产与FEV1/FVC比值降低或慢阻肺无关。
要点
- 极至中度早产(28周至<34周)与53岁时慢阻肺风险增加相关(OR 2.9,95%CI 1.1-7.7)。
- 极至中度早产与53岁时支气管舒张后FEV1/FVC比值降低(β=-2.9%,95%CI -4.9至-0.81)、FEV1降低(-190 mL,95%CI -339至-40)相关。
- 极至中度早产与FEV1/FVC比值的关联仅在吸烟者中显著(交互作用P=0.0082),效应被个人吸烟叠加放大。
- 晚期早产(34周至<37周)与FEV1/FVC比值降低或慢阻肺无关。
- 极至中度早产还与DLCO降低(-0.55 mmol/min/kPa,95%CI -0.97至-0.13)和FEF25-75%降低(-339 mL/s,95%CI -664至-14)相关。
适用人群与场景
- 塔斯马尼亚纵向健康研究(TAHS)队列中具有孕周数据的3565人中的1445名参与者(占41%),其中女性740人(51%)。
- 在53岁时进行肺功能测量。
诊断标准与关键阈值
- 孕周分组:极早产为28周至<32周,中度早产为32周至<34周,晚期早产为34周至<37周,足月为≥37周。
- 慢阻肺定义为支气管舒张后FEV1/FVC低于正常下限(lower limit of normal)。
研究设计与关键结果
- 研究类型:前瞻性队列研究(TAHS),样本量1445人,人群为53岁参与者。
- 与足月产相比,极至中度早产与53岁时慢阻肺风险增加显著相关(OR 2.9,95%CI 1.1-7.7)。
- 极至中度早产与支气管舒张后FEV1/FVC比值降低相关(β=-2.9%,95%CI -4.9至-0.81)。
- 极至中度早产与FEV1降低相关(-190 mL,95%CI -339至-40)。
- 极至中度早产与DLCO降低相关(-0.55 mmol/min/kPa,95%CI -0.97至-0.13)。
- 极至中度早产与FEF25-75%降低相关(-339 mL/s,95%CI -664至-14)。
- 极至中度早产与FEV1/FVC比值的关联仅在吸烟者中显著(交互作用P=0.0082)。
- 中度早产作为单独组分析时观察到类似结果;与足月产相比,晚期早产与FEV1/FVC比值降低或慢阻肺无关。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 调整因素:性别、年龄、身高、孕期父母吸烟、年长兄弟姐妹数、母亲生育年龄和儿童期社会经济状况。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,极至中度早产与阻塞性肺功能缺陷(包括慢阻肺)相关,并持续至第六个十年,且该效应被个人吸烟叠加放大。
- 晚期早产与FEV1/FVC比值降低或慢阻肺无关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Prematurity has been linked to reduced lung function up to age 33 years, but its long-term effects on lung function and chronic obstructive pulmonary disease (COPD) are unknown. To address this question, we investigated associations between prematurity, lung function, and COPD in the sixth decade of life using data from the Tasmanian Longitudinal Health Study (TAHS).
METHODS: Data were analysed from 1445 participants in the TAHS. Lung function was measured at 53 years of age. Gestational ages were very preterm (28 weeks to <32 weeks), moderate preterm (32 weeks to <34 weeks), late preterm (34 weeks to <37 weeks) and term (≥37 weeks). Linear and logistic regression models were fitted to investigate associations of prematurity with lung function measures (FEV1, forced vital capacity [FVC], FEV1/FVC ratio, forced expiratory flow at 25-75% of FVC [FEF25-75%], diffusing capacity for carbon monoxide [DLCO]) and COPD (post-bronchodilator FEV1/FVC less than the lower limit of normal), adjusting for sex, age, height, parental smoking during pregnancy, number of older siblings, maternal age at birth, and childhood socioeconomic status. Interactions with smoking and asthma were also investigated.
RESULTS: Of 3565 individuals with available data on gestational age from the TAHS cohort, 1445 (41%) participants were included in this study, 740 (51%) of whom were female. Compared with term birth, very to moderate preterm birth was significantly associated with an increased risk of COPD at age 53 years (odds ratio 2·9 [95% CI 1·1-7·7]). Very-to-moderate preterm birth was also associated with lower post-bronchodilator FEV1/FVC ratio (beta-coefficient -2·9% [95% CI -4·9 to -0·81]), FEV1 (-190 mL [-339 to -40]), DLCO (-0·55 mmol/min/kPa [-0·97 to -0·13]), and FEF25-75% (-339 mL/s [-664 to -14]). The association between very-to-moderate preterm birth and FEV1/FVC ratio was only significant among smokers (pinteraction=0·0082). Similar findings were observed for moderate preterm birth when analysed as a separate group. Compared with term birth, late preterm birth was not associated with lower FEV1/FVC ratio or COPD.
INTERPRETATION: This is the first study to investigate the effect of prematurity on lung function into middle-age. Data show that very-to-moderate prematurity is associated with obstructive lung function deficits including COPD well into the sixth decade of life and that this effect is compounded by personal smoking.
FUNDING: National Health and Medical Research Council (NHMRC) of Australia, European Union's Horizon 2020, The University of Melbourne, Clifford Craig Medical Research Trust of Tasmania, The Victorian, Queensland & Tasmanian Asthma Foundations, The Royal Hobart Hospital, Helen MacPherson Smith Trust, and GlaxoSmithKline.
参考来源
- Bui DS, Perret JL, Walters EH, et al. Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort study. Lancet Respir Med. 2022. PMID: 35189074. doi:10.1016/S2213-2600(21)00508-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。